Global Virus-like Particle Vaccine Market Size
Key players operating in the global virus-like particle vaccine market include Novavax, GlaxoSmithKline, Merck & Co., Medicago, Dynavax Technologies, Cytos Biotechnology, iBio, Sanofi Pasteur, Bavarian Nordic, and GeoVax Labs, among others.
Brooklyn, New York, Oct. 09, 2023 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the global virus-like particle vaccine market is expected to grow at a CAGR of 7.8% from 2023 to 2028.
Advances in biotechnology, such as genetic engineering and protein expression technologies, have made it more cost-effective and efficient to produce VLPs. This has reduced barriers to entry for vaccine development.
Key Market Insights
- As per the stage outlook, the approved vaccines segment is expected to be the largest segment during the forecast period
- As per the application type outlook, the infectious disease segment is projected to be the largest segment during the forecast period
- Asia Pacific region is analyzed to be the fastest-growing region in the market
- North America region is analyzed to account for largest share in the global market during the forecast period of 2023-2028
- Key players operating in the global virus-like particle vaccine market include Novavax, GlaxoSmithKline, Merck & Co., Medicago, Dynavax Technologies, Cytos Biotechnology, iBio, Sanofi Pasteur, Bavarian Nordic, and GeoVax Labs, among others
Request for a Sample Copy of the Report: https://www.globalmarketestimates.com/market-report/virus-like-particle-vaccine-market-4186
By Distribution Channel (Revenue, USD Billion, 2023-2028)
- Healthcare Providers
- Retail Pharmacies
- Government Vaccination Programs
By Stage (Revenue, USD Billion, 2023-2028)
- Pre-clinical Research Stage
- Approved Vaccines
By Application Type (Revenue, USD Billion, 2023-2028)
- Infectious Diseases
- Cancer Immunotherapy
- Others
By Regional Outlook (Revenue, USD Billion, 2023-2028)
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Netherlands
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Thailand
- Indonesia
- Malaysia
- Singapore
- Vietnam
- Rest of APAC
Central and South America
- Brazil
- Argentina
- Chile
- Rest of CSA
Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of MEA
Browse 147 Market Data Tables and 115 Figures spread through 163 Pages and in-depth TOC on “Global Virus-Like Particle Vaccine Market - Forecast to 2028’’
Contact: Yash Jain
Director - Global Accounts & Strategic Advisory
Email address: yash.jain@globalmarketestimates.com
Phone Number: +1 6026667238
LinkedIn: https://www.linkedin.com/in/yash-jain-global-market-estimates/
Website: www.globalmarketestimates.com
Attachment
Contact: Yash Jain Director - Global Accounts & Strategic Advisory Email address: yash.jain@globalmarketestimates.com Phone Number: +1 6026667238 LinkedIn: https://www.linkedin.com/in/yash-jain-global-market-estimates/ Website: www.globalmarketestimates.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
